China's Asymchem Biotechnology to raise $392m from Hillhouse, others

China's Asymchem Biotechnology to raise $392m from Hillhouse, others

Photo by Raimond Klavins on Unsplash

28 March, 2022

Asymchem Biotechnology Asymchem Laboratories CDMO Hillhouse Capital Group

Printed by Unregistered user on Sat, 12 Jul 2025 13:14:46 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

The rise of the China-focused private equity giant Hillhouse

US pension fund TCDRS commits $46m to Hillhouse Capital's latest vehicle

Read more from Greater China

Policy & Regulations

Shanghai to consider policy responses to stablecoins, cryptocurrencies

Policy & Regulations

China’s Chery, BYD may have to repay subsidies after audit finds improper claims